The effects of levosimendan in patients undergoing transcatheter aortic valve replacement- a retrospective analysis

Background: Aortic stenosis (AS) increases left ventricular afterload, leading to cardiac damage and heart failure (HF). Transcatheter aortic valve replacement (TAVR) is an effective therapy for AS. No inotropic agents including levosimendan have been evaluated in patients undergoing TAVR. Methods:...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Zhao, Zhenyan, Meng, Zhen, Song, Guangyuan, Wang, Chunrong, Shi, Sheng, Zhao, Jie, Zhang, Hongliang, Wang, Moyang, Niu, Guannan, Zhou, Zheng, Wang, Jianhui, Wu, Yongjian
Fformat: Online Erthygl Texto
Iaith:English
Cyhoeddwyd: Frontiers Media S.A. 2022
Pynciau:
Pharmacology
Mynediad Ar-lein:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669067/
https://www.ncbi.nlm.nih.gov/pubmed/36408223
http://dx.doi.org/10.3389/fphar.2022.969088

Rhyngrwyd

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669067/
https://www.ncbi.nlm.nih.gov/pubmed/36408223
http://dx.doi.org/10.3389/fphar.2022.969088

Eitemau Tebyg